Wednesday |
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/22/23
- Petco falls 7% to $9.44 after Q4 results, FY23 guidance
- 03/22/23
- Freshpet, Petco announce delivery partnership
- 03/22/23
- Petco expects to make $100M in principal payments on term loan in FY23
- 03/22/23
- Petco sees FY23 CapEx $225M-$250M
- 03/20/23
- S&P revises UBS Group outlook to Negative, affirms ratings
- 03/20/23
- UBS rises 7.9%
- 03/19/23
- Fly Intel: Top five weekend stock stories
- 03/19/23
- Credit Suisse says UBS confident staff employment will be continued
- 03/22/23
- Senators Scott, Warren unveil bipartisan Fed oversight legislation
- 03/01/23
- Einhorn says not invested long in artificial intelligence companies
- 03/01/23
- Einhorn says investors should be 'bearish on stocks and bullish on inflation'
- 12/14/22
- SEC proposes rules to enhance competition for retail order flow execution
- 02/08/23
- CMS grants Spectrum permanent J-Code for Rolvedon injection
- 01/04/23
- Spectrum announces that CMO Francois Lebel, M.D. steps down
- 12/06/22
- Spectrum announces Rolvedon added to latest NCCN Guidelines
- 11/25/22
- Spectrum receives CRL from FDA regarding NDA for poziotinib
- 03/08/23
- Spotify introduces Spotify for Podcasters, offering more 'access to innovation'
- 01/31/23
- Spotify rises 9.8%
- 01/31/23
- Spotify reports Q4 MAUs up 20% y/y to 489M
- 01/26/23
- Spotify tweets 'everything's looking much better now'
- 03/20/23
- Charles Schwab director buys $200K in common stock
- 03/17/23
- Charles Schwab reports $16.5B in core net new assets over past five trading days
- 03/16/23
- Charles Schwab director buys $233.5K in common stock
- 03/15/23
- Charles Schwab director buys $2.0M in common stock
- 03/22/23
- Pacific Western Bank determines not to move forward with capital raise
- 03/22/23
- Pacific Western Bank reports $11.4B in available cash as of March 20
- 03/20/23
- PacWest Bancorp says bank continues to have 'solid liquidity'
- 03/16/23
- PacWest Bancorp trading resumes
OLLI Ollie's Bargain Outlet - 03/22/23
- Ollie's Bargain Outlet jumps 11% to $59.00 after Q4 earnings beat and FY23 guide
- 10/17/22
- Ollie's Bargain Outlet appoints Rob Helm as CFO
- 03/21/23
- Novartis alpelisib granted FDA orphan designation
- 03/21/23
- Novartis' Sandoz receives FDA approval for biosimilar Hyrimoz HCF
- 03/17/23
- Novartis terminates collaboration and license pact with Sangamo
- 03/16/23
- Novartis' Tafinlar + Mekinist approved by FDA for pediatric patients
- 03/21/23
- Nike pares afterhours gains, down 0.9% after Q4 and FY23 outlook
- 03/21/23
- Nike jumps 4% to $131.00 after Q3 earnings beat
- 03/21/23
- Nike reports Q3-end inventories at $8.9B, up 16% from last year
- 03/21/23
- Nike reports Direct sales up 17% at $5.3B
- 03/21/23
- Nvidia announces availability of new products featuring H100 Tensor Core GPU
- 03/15/23
- Facebook Ireland violated law over data use, Amsterdam court ruled
- 03/15/23
- Oportun Financial expands executive team with key new hires
- 03/14/23
- Meta targeting summer to complete analysis from hybrid work year of learning
- 02/28/23
- Luminar off earlier highs, goes red after Q4 business update at 'Luminar Day'
- 02/28/23
- Luminar unveils new Iris+ sensor, announces Luminar AI Engine
- 02/28/23
- Luminar partners with Swiss Re to launch insurance program
- 02/22/23
- Luminar up 15% to $6.62 after announcing expansion of Mercedes-Benz partnership
- $242.70 /
-0.305 (-0.13%) - 02/21/23
- Bath & Body Works appoints Hershey CFO Voskuil to board
- 12/07/22
- Hershey announces first bilingual manufacturing facility
- 10/20/22
- Hershey signs new solar power purchase agreement with National Grid Renewables
- 02/15/23
- Host Hotels provides RevPAR outlook for next three quarters
- 02/15/23
- Host Hotels provides update on Hurricane Ian damage
- 12/15/22
- Host Hotels board authorizes special dividend of 20c per share
- 11/29/22
- Host Hotels appoints Mari Sifo as EVP, Chief Human Resources Officer
- 01/09/23
- HealthEquity announces HSA sales outlook
- 09/22/22
- Director of HealthEquity Sacks sells $1.8M in company shares
- 09/22/22
- Director of HealthEquity Sacks sells $1.8M in company shares
- 03/21/23
- Nvidia says Google Cloud integrating newly launched L4 GPU, Vertex AI
- 03/17/23
- YouTube restores Donald Trump's channel
- 03/17/23
- Google ends enterprise sales of Google Glass
- 03/16/23
- YouTube TV raises monthly price to $72.99 from $64.99
- 03/22/23
- GameStop rises 40.7%
- 03/22/23
- GameStop rises 32.9%
- 03/22/23
- GameStop rises 45.0%
- 03/21/23
- GameStop jumps nearly 33% to over $23 after reporting Q4 profit
- 03/22/23
- 89bio up 47% to $16.10 after announcing positive pegozafermin trial data
- 03/22/23
- 89bio's pegozafermin trial statistically significant in critical histology
- 03/05/23
- 89bio presents new analysis of data from Phase 2 ENTRIGUE trial of pegozafermin
- 12/12/22
- 89bio announces publication of Phase 1b/2a pegozafermin study results
- 02/27/23
- Krispy Kreme confirms expanded market test with McDonald's
- 12/15/22
- Krispy Kreme down 4% amid investor day presentations
- 10/18/22
- Krispy Kreme up 8% after reports of McDonald's testing donut sales partnership
- 09/26/22
- Krispy Kreme offers free coffee on National Coffee Day
- 03/22/23
- Major Carvana bondholders reportedly to oppose restructuring plan
- 03/22/23
- Carvana rises 23.6%
- 03/22/23
- Carvana rises 16.3%
- 03/22/23
- Carvana rises 22.8%
- 02/23/23
- Alibaba jumps 6% to $100.65 after Q3 results beat estimates
- 02/23/23
- Alibaba CEO sees 'continued recovery in consumer sentiment'
- 02/14/23
- Appaloosa takes stake in Disney, exits position in Mosaic
- 01/31/23
- Iqvia teams with Alibaba for cloud commercial & clinical solutions in China
- $196.11 /
-8.595 (-4.20%) - 03/17/23
- Boeing awarded $1.95B Army contract modification
- 03/14/23
- Boeing reports 28 commercial airplane deliveries, 5 orders in February
- 03/14/23
- Saudi Arabian Airlines selects up to 49 Boeing 787 Dreamliners
- 03/14/23
- Riyadh Air choses Boeing 787 Dreamliner to power its global launch
- 03/15/23
- Array Technologies reschedules earnings, needs more time to file annual report
- 03/03/23
- Avangrid announces intent to deploy more than $30M in solar trackers from Array
- 01/30/23
- Array Technologies names Manning as Chief Operations Officer
- 11/08/22
- Array Technologies appoints Jokinen to board of directors
- 03/21/23
- Altimmune falls 35% to $7.15 after initerim MOMENTUM Phase 2 trial data
- 03/21/23
- Altimmune announces reuslts from interim analysis of MOMENTUM Phase 2 trial
- 01/04/23
- Altimmune appoints Jordt as Chief Business Officer
- 12/20/22
- Altimmune announces topline results from 24-week trial of pemvidutide
- $153.67 /
-3.155 (-2.01%) - 03/22/23
- AbbVie receives CRL from FDA for NDA for ABBV-951
- 03/19/23
- AbbVie announces late-breaking results for SKYRIZI study
- 02/27/23
- AbbVie receives CHMP opinion recommending approval for upadacitinib
- 02/23/23
- AbbVie, Capsida announce expanded genetic medicines for eye diseases pact
- 03/22/23 BofA
- Nike inventory progress coming at expense of margins, says BofA
- 03/22/23 Evercore ISI
- Nike added to 'Tactical Outperform' list at Evercore ISI
- 03/22/23 Piper Sandler
- Nike price target raised to $112 from $105 at Piper Sandler
- 03/22/23 Jefferies
- Nike price target raised to $160 from $140 at Jefferies
- $153.67 /
-3.155 (-2.01%) - 03/16/23 Chardan
- Immunome price target lowered to $8 from $9 at Chardan
- 03/01/23 Guggenheim
- Guggenheim starts AbbVie with a Buy on diversified growth
- 02/28/23 Guggenheim
- AbbVie initiated with a Buy at Guggenheim
- 02/22/23 BMO Capital
- AbCellera price target lowered to $32 from $40 at BMO Capital
- 03/23/23 Piper Sandler
- PacWest 'can make it to the other side,' says Piper Sandler
- 03/22/23 RBC Capital
- PacWest provides detailed update on deposit balances, says RBC Capital
- 03/20/23 Piper Sandler
- Piper confident PacWest can make it through liquidity crunch
- 03/20/23 DA Davidson
- PacWest Bancorp price target lowered to $26 from $29 at DA Davidson
- 12/08/22 Wedbush
- GameStop price target lowered to $5.30 from $6 at Wedbush
- 10/13/22 Jefferies
- GameStop transferred with a Hold at Jefferies
- 08/16/22 B. Riley
- B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell
- 07/22/22 Wedbush
- GameStop price target lowered to $7.50 from $30 at Wedbush
- 03/20/23 Citi
- Citi sees 25 basis point hike from Fed on Wednesday
- 03/17/23 JPMorgan
- JPMorgan expects 25 point hike from Federal Reserve next week
- 03/07/23 JPMorgan
- JPMorgan says 'spooked' Powell opened door to 50 point hike
- 02/13/23 JPMorgan
- Stock market risk/reward 'skewed to the downside,' says JPMorgan
SPY SPDR S&P 500 ETF Trust - 03/22/23 KeyBanc
- Meta Platforms upgraded to Overweight from Sector Weight at KeyBanc
- 03/21/23 Morgan Stanley
- Meta Platforms upgraded to Overweight from Equal Weight at Morgan Stanley
- 03/20/23 Loop Capital
- Meta Platforms price target raised to $220 from $188 at Loop Capital
- 03/20/23 Edward Jones
- Meta Platforms upgraded to Buy from Hold at Edward Jones
- 03/22/23 Guggenheim
- Spotify upgraded to Buy at Guggenheim on music industry growth potential
- 03/22/23 Guggenheim
- Spotify upgraded to Buy from Neutral at Guggenheim
- 03/10/23 BofA
- Spotify price target raised to $143 from $120 at BofA
- 03/01/23 Redburn
- Spotify upgraded to Buy from Neutral at Redburn
- 03/22/23 Stifel
- Stifel argues sympathy trading not a predictor for Viking's pending VK2735 data
- 03/21/23 Goldman Sachs
- Altimmune downgraded to Neutral from Buy at Goldman Sachs
- 03/21/23 William Blair
- William Blair says Viking bull thesis intact after Altimmune data
- 03/21/23 H.C. Wainwright
- Altimmune attractive after 'overdone' selloff, says H.C. Wainwright
- 03/22/23 Truist
- Krispy Kreme upgraded to Buy at Truist on volume growth, FX tailwinds
- 03/22/23 Truist
- Krispy Kreme upgraded to Buy from Hold at Truist
- 02/14/23 HSBC
- Krispy Kreme price target lowered to $14 from $15 at HSBC
- 01/17/23 Morgan Stanley
- Krispy Kreme downgraded to Equal Weight from Overweight at Morgan Stanley
- 03/21/23 Goldman Sachs
- Luminar downgraded to Sell from Neutral at Goldman Sachs
- 03/14/23 Citi
- Luminar price target lowered to $19 from $20 at Citi
- 03/06/23 JPMorgan
- Luminar price target raised to $20 from $15 at JPMorgan
- 03/01/23 Deutsche Bank
- Luminar price target lowered to $14 from $15 at Deutsche Bank
- 01/26/23 Citi
- Novartis downgraded to Neutral from Buy at Citi
- 01/24/23 Lake Street
- Harrow Health price target raised to $24 from $17 at Lake Street
- 01/06/23 Morgan Stanley
- Novartis downgraded to Underweight from Equal Weight at Morgan Stanley
- 01/03/23 JPMorgan
- Novartis upgraded to Neutral from Underweight at JPMorgan
- 03/20/23 Barclays
- European Banks sector view downgraded to Neutral at Barclays
- 03/20/23 Societe Generale
- UBS downgraded to Hold from Buy at Societe Generale
- 03/20/23 Keefe Bruyette
- UBS downgraded to Underperform from Market Perform at Keefe Bruyette
- 03/20/23 BofA
- UBS upgraded to Buy from Neutral at BofA
- 02/28/23 Susquehanna
- Alibaba price target lowered to $175 from $185 at Susquehanna
- 02/24/23 UBS
- Vipshop upgraded to Buy at UBS on apparel demand recovery
- 02/24/23 Truist
- Alibaba price target raised to $130 from $120 at Truist
- 02/24/23 KGI Securities
- Alibaba upgraded to Outperform from Neutral at KGI Securities
- $196.11 /
-8.595 (-4.20%) - 03/23/23 Susquehanna
- Boeing orders from Japan sign of strong demand, says Susquehanna
- 03/23/23 Wolfe Research
- Boeing under $200 brings attractive entry point, says Wolfe Research
- 03/22/23 Wells Fargo
- Boeing price target lowered to $230 from $240 at Wells Fargo
- 03/16/23 Northcoast
- Boeing initiated with a Neutral at Northcoast
- 03/21/23 Morgan Stanley
- Microsoft app store longer-term Apple risk 'worth watching,' says Morgan Stanley
- 03/20/23 Stifel
- Alphabet resumed with a Buy at Stifel
- 03/17/23 Exane BNP Paribas
- Alphabet upgraded to Outperform from Neutral at Exane BNP Paribas
- 03/16/23 Macquarie
- Microsoft 'clear winner' in ongoing generative AI fight, says Macquarie
- 03/22/23 Oppenheimer
- 89bio price target raised to $33 from $18 at Oppenheimer
- 03/22/23 H.C. Wainwright
- 89bio price target raised to $30 from $25 at H.C. Wainwright
- 03/22/23 Raymond James
- Raymond James doubles 89bio price target to $50 after FGF21 'wins again'
- 03/22/23 Raymond James
- 89bio price target raised to $50 from $25 at Raymond James
- 03/23/23 JPMorgan
- Carvana business de-scaling overshadows cost cuts, says JPMorgan
- 03/23/23 Citi
- Citi encouraged with accelerating retail unit sales at Carvana
- 03/22/23 Raymond James
- Carvana navigating difficult operating environment, says Raymond James
- 02/27/23 Citi
- Carvana price target raised to $11 from $5.50 at Citi
OLLI Ollie's Bargain Outlet - 03/22/23 Goldman Sachs
- Ollie's Bargain Outlet price target raised to $61 from $56 at Goldman Sachs
- 02/28/23 Piper Sandler
- Ollie's Bargain Outlet price target raised to $72 from $60 at Piper Sandler
- 02/06/23 Wells Fargo
- Ollie's Bargain Outlet price target raised to $67 from $60 at Wells Fargo
- 12/08/22 Jefferies
- Ollie's Bargain Outlet price target lowered to $60 from $65 at Jefferies
- 03/22/23 Barclays
- Charles Schwab price target lowered to $61 from $79 at Barclays
- 03/15/23 Credit Suisse
- Charles Schwab upgraded to Outperform from Neutral at Credit Suisse
- 03/14/23 JPMorgan
- Schwab funding concerns 'significantly de-risked,' says JPMorgan
- 03/14/23 Piper Sandler
- Charles Schwab price target lowered to $95 from $100 at Piper Sandler
- 03/22/23 Compass Point
- Host Hotels downgraded to Neutral from Buy at Compass Point
- 02/16/23 Stifel
- Host Hotels price target lowered to $21 from $22 at Stifel
- 01/09/23 Jefferies
- Hilton downgraded to Hold from Buy at Jefferies
- 01/09/23 Jefferies
- Marriott downgraded to Hold from Buy at Jefferies
- 03/22/23 Guggenheim
- Array Technologies price target lowered to $35 from $36 at Guggenheim
- 03/09/23 Citi
- Array Technologies initiated with a Neutral at Citi
- 03/07/23 Piper Sandler
- Array Technologies price target lowered to $26 from $28 at Piper Sandler
- 03/01/23 Scotiabank
- Array Technologies initiated with an Outperform at Scotiabank
- $242.70 /
-0.305 (-0.13%) - 03/20/23 Deutsche Bank
- Hershey price target lowered to $237 from $246 at Deutsche Bank
- 03/17/23 Erste Group
- Hershey upgraded to Buy from Hold at Erste Group
- 02/02/23 Goldman Sachs
- Hershey price target raised to $277 from $255 at Goldman Sachs
- 01/06/23 Evercore ISI
- Hershey downgraded to In Line from Outperform at Evercore ISI
- 03/23/23 Baird
- Petco price target lowered to $11 from $14 at Baird
- 03/23/23 Morgan Stanley
- Petco price target lowered to $10 from $12 at Morgan Stanley
- 03/22/23 Baird
- Petco price target lowered to $11 from $14 at Baird
- 03/15/23 Wedbush
- Petco price target lowered to $12 from $17 at Wedbush
- 02/03/23 Wells Fargo
- HealthEquity price target lowered to $89 from $101 at Wells Fargo
- 01/24/23 Deutsche Bank
- HealthEquity price target raised to $72 from $68 at Deutsche Bank
- 01/03/23 BTIG
- Sharecare named Top Pick for first half of 2023 at BTIG
- 12/16/22 Baird
- HealthEquity bullish Fresh Pick designation extended at Baird
- 01/31/23 H.C. Wainwright
- Spectrum Q4 sales dramatically beat estimates, says H.C. Wainwright
- 11/25/22 H.C. Wainwright
- Spectrum price target lowered to $4 from $6 at H.C. Wainwright
- 11/16/22 B. Riley
- Spectrum downgraded to Neutral from Buy at B. Riley
- 09/23/22 H.C. Wainwright
- Spectrum price target lowered to $6 from $9 at H.C. Wainwright
- 03/22/23
- Petco sees FY23 revenue $6.15B-$6.275B, consensus $6.36B
- 03/22/23
- Petco reports Q4 adjusted EPS 23c, consensus 24c
- 01/31/23
- UBS reports Q4 EPS 50c, profit before tax $1.9B
- 10/25/22
- UBS reports Q3 EPS 52c, net profit $1.7B
- 03/22/23
- Spectrum reports Q4 EPS (5c), consensus (11c)
- 01/31/23
- Spectrum rallies after preliminary Q4 sales crush estimates
- 11/10/22
- Spectrum reports Q3 EPS (12c), consensus (15c)
- 01/31/23
- Spotify sees Q1 revenue EUR 3.1B, gross margin 24.9%
- 01/31/23
- Spotify reports Q4 EPS (EUR 1.40) vs. (EUR 0.20) last year
- 10/25/22
- Spotify reports Q3 Operating loss EUR (228M) vs. profit EUR 75M prior
- 01/18/23
- Charles Schwab reports Q4 adjusted EPS $1.07, consensus $1.09
- 01/17/23
- Notable companies reporting before tomorrow's open
- 10/27/22
- Charles Schwab backs 11%-13% year-over-year revenue growth outlook
- 01/26/23
- PacWest Bancorp reports Q4 EPS 33c, consensus 97c
- 10/19/22
- PacWest Bancorp reports Q3 EPS 1.02, consensus $1.07
OLLI Ollie's Bargain Outlet - 03/22/23
- Ollie's Bargain Outlet sees 2023 adjusted EPS $2.49-$2.58, consensus $2.38
- 03/22/23
- Ollie's Bargain Outlet reports Q4 adjusted EPS 84c, consenus 79c
- 03/21/23
- Notable companies reporting before tomorrow's open
- 02/01/23
- Novartis sees core operating income to grow mid single digit percentage in 2023
- 02/01/23
- Novartis reports Q4 core EPS $1.52, consensus $1.44
- 10/25/22
- Novartis confirms mid single digit sales, core operating income guidance
- 10/25/22
- Novartis reports Q3 core EPS $1.58 vs. $1.71 last year
- 03/21/23
- Nike sees FY23 revenue up high single digits, gross margins down 250bps
- 03/21/23
- Nike reports Q3 EPS 79c, consensus 55c
- 03/21/23
- Notable companies reporting after market close
- 12/20/22
- Nike sees FY23 revenue growth in mid teens, consensus $49.01B
- 02/01/23
- Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B
- 02/01/23
- Meta Platforms reports Q4 EPS $1.76, consensus $2.22
- 02/01/23
- Notable companies reporting after market close
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 02/28/23
- Luminar sees FY23 revenue growth of 'at least 100%,' consensus $116.14M
- 02/28/23
- Luminar reports Q4 EPS (26c), consensus (21c)
- 11/02/22
- Luminar reports Q3 EPS (18c), consensus (20c)
- 11/02/22
- Notable companies reporting after market close
- $242.70 /
-0.305 (-0.13%) - 03/22/23
- Hershey backs FY23 adjusted EPS growth view 9%-11%, consensus $9.35
- 02/02/23
- Hershey sees FY23 adjusted EPS up 9%-11%, consensus $8.94
- 02/02/23
- Hershey reports Q4 adjusted EPS $2.02, consensus $1.77
- 02/01/23
- Notable companies reporting before tomorrow's open
- 02/15/23
- Host Hotels reports Q4 EPS 20c, consensus 19c
- 11/02/22
- Host Hotels reports Q3 EPS 16c, consensus 17c
- 03/21/23
- HealthEquity sees FY24 EPS $1.74-$1.87, consensus $1.76
- 03/21/23
- HealthEquity reports Q4 EPS 0c, consensus 35c
- 12/06/22
- HealthEquity sees FY24 revenue $950M-$970M, consensus $948.4M
- 12/06/22
- HealthEquity raises FY23 EPS view to $1.26-$1.35 from $1.23-$1.32
- 02/02/23
- Alphabet reports Q4 EPS $1.05, consensus $1.18
- 02/02/23
- Notable companies reporting after market close
- 10/25/22
- Alphabet reports Q3 EPS $1.06, consensus $1.25
- 10/25/22
- Notable companies reporting after market close
- 03/21/23
- GameStop reports Q4 EPS 16c, consensus (13c)
- 12/07/22
- GameStop reports Q3 EPS (31c), consensus (28c)
- 03/10/23
- 89bio reports Q4 EPS (48c), consensus (69c)
- 11/10/22
- 89bio reports Q3 EPS (57c), consensus (80c)
- 02/15/23
- Krispy Kreme sees FY23 adjusted EPS 31c-34c, consensus 36c
- 02/15/23
- Krispy Kreme reports Q4 adjusted EPS 11c, consensus 10c
- 12/15/22
- Krispy Kreme sees FY26 revenue about $2.15B, adjusted EPS about 53c
- 12/15/22
- Krispy Kreme sees FY23 revenue up low double digits in constant currency
- 03/22/23
- Carvana sees Q1 revenue $2.4B-$2.6B, consensus $2.7B
- 02/23/23
- Carvana reports Q4 EPS ($7.61) vs ($1.02) last year
- 02/23/23
- Notable companies reporting after market close
- 11/03/22
- Carvana sees sequential reduction in retail units sold in Q4
- 02/23/23
- Alibaba reports Q3 adjusted EPS $2.79, consensus $2.37
- 02/22/23
- Notable companies reporting before tomorrow's open
- 11/17/22
- Alibaba reports Q2 adjusted EPS $1.82, consensus $1.64
- $196.11 /
-8.595 (-4.20%) - 01/25/23
- Boeing reports Q4 core EPS ($1.75), consensus 26c
- 01/24/23
- Notable companies reporting before tomorrow's open
- 10/26/22
- Boeing reports Q3 core EPS ($6.18), consensus 2c
- 03/21/23
- Array Technologies sees FY23 adjusted EPS 75c-85c, consensus 78c
- 03/21/23
- Array Technologies reports Q4 adjusted EPS 10c, consensus 8c
- 03/02/23
- Array Technologies sees 2023 adjusted EPS 75c-85c, consensus 95c
- 02/28/23
- Altimmune reports Q4 EPS (43c), consensus (50c)
- 11/10/22
- Altimmune reports Q3 EPS (48c), consensus (50c)
- $153.67 /
-3.155 (-2.01%) - 02/09/23
- AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08
- 02/09/23
- AbbVie sees FY23 revenue about $52B, consensus $54.21B
- 02/09/23
- AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65
- 02/09/23
- AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56
|
Hot Stocks
|
Carvana shares, which had… Carvana shares, which had jumped as much as 29%, have pared gains to about 9% on Wednesday following a Bloomberg report saying that a group of funds holding most of Carvana's more than $5 billion in bonds will oppose a restructuring plan that the online auto seller wants as a way to rein in its debt load. Carvana said Wednesday it would offer to exchange as much as $1 billion of its unsecured bonds at discount prices in an effort to extend looming repayment deadlines. Bondholders that banded together late last year to negotiate with Carvana see the new proposal as a nonstarter, Bloomberg's Eliza Ronalds-Hannon and Rachel Butt reported, citing people familiar with the matter. Together, the group holds more than 80% of Carvana's debt, putting it in a position to block debt restructuring efforts. Reference Link ShowHide Related Items >><< - 03/22/23
- Carvana rises 23.6%
- 03/22/23
- Carvana rises 16.3%
- 03/22/23
- Carvana rises 22.8%
- 03/22/23
- Carvana trading resumes
- 03/22/23 Raymond James
- Carvana navigating difficult operating environment, says Raymond James
- 02/27/23 Citi
- Carvana price target raised to $11 from $5.50 at Citi
- 02/24/23 Deutsche Bank
- Carvana price target lowered to $10 from $16 at Deutsche Bank
- 02/24/23 BofA
- Carvana price target raised to $12 from $10 at BofA
- 03/22/23
- Carvana sees Q1 revenue $2.4B-$2.6B, consensus $2.7B
- 02/23/23
- Carvana reports Q4 EPS ($7.61) vs ($1.02) last year
- 02/23/23
- Notable companies reporting after market close
- 11/03/22
- Carvana sees sequential reduction in retail units sold in Q4
|
Periodicals
|
A group of investors… A group of investors holding most of Carvana's more than $5B in bonds will oppose the restructuring plan that the auto seller has put forward, sources tell Bloomberg's Eliza Ronalds-Hannon and Rachel Butt. ShowHide Related Items >><< - 03/22/23
- Carvana rises 23.6%
- 03/22/23
- Carvana rises 16.3%
- 03/22/23
- Carvana rises 22.8%
- 03/22/23
- Carvana trading resumes
- 03/22/23 Raymond James
- Carvana navigating difficult operating environment, says Raymond James
- 02/27/23 Citi
- Carvana price target raised to $11 from $5.50 at Citi
- 02/24/23 Deutsche Bank
- Carvana price target lowered to $10 from $16 at Deutsche Bank
- 02/24/23 BofA
- Carvana price target raised to $12 from $10 at BofA
- 03/22/23
- Carvana sees Q1 revenue $2.4B-$2.6B, consensus $2.7B
- 02/23/23
- Carvana reports Q4 EPS ($7.61) vs ($1.02) last year
- 02/23/23
- Notable companies reporting after market close
- 11/03/22
- Carvana sees sequential reduction in retail units sold in Q4
|
Recommendations
|
Raymond James analyst… Raymond James analyst Mitch Ingles reaffirms a Market Perform rating on shares of Carvana. The firm's thesis remains relatively unchanged after Carvana's business update, saying Carvana is navigating a difficult operating environment while also integrating 46 inspection centers from the ADESA acquisition, the analyst tells investors in a research note. Raymond James believes Carvana has a long runway for growth in the coming years, but sees a more favorable entry point likely a few quarters away if it can show sustainable EBITDA margin progress. ShowHide Related Items >><< - 03/22/23
- Carvana rises 23.6%
- 03/22/23
- Carvana rises 16.3%
- 03/22/23
- Carvana rises 22.8%
- 03/22/23
- Carvana trading resumes
- 02/27/23 Citi
- Carvana price target raised to $11 from $5.50 at Citi
- 02/24/23 Deutsche Bank
- Carvana price target lowered to $10 from $16 at Deutsche Bank
- 02/24/23 BofA
- Carvana price target raised to $12 from $10 at BofA
- 02/24/23 Wedbush
- Wedbush keeps $1 target on Carvana after 'awful' quarter
- 03/22/23
- Carvana sees Q1 revenue $2.4B-$2.6B, consensus $2.7B
- 02/23/23
- Carvana reports Q4 EPS ($7.61) vs ($1.02) last year
- 02/23/23
- Notable companies reporting after market close
- 11/03/22
- Carvana sees sequential reduction in retail units sold in Q4
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/22/23
- Petco falls 7% to $9.44 after Q4 results, FY23 guidance
- 03/22/23
- Freshpet, Petco announce delivery partnership
- 03/22/23
- Petco expects to make $100M in principal payments on term loan in FY23
- 03/22/23
- Petco sees FY23 CapEx $225M-$250M
- 01/23/23
- Warner Music acquires recorded music rights to English band Yes' catalog
- 12/15/22
- Warner Music announces partnership with DRESSX
- 12/02/22
- Warner Music director Benet sells 15,000 class A common shares
- 11/09/22
- OverActive Media, Warner Music Spain extend commercial partnership agreement
- 03/22/23
- Virgin Orbit confirms incremental resumption of operations
- 03/16/23
- Virgin Orbit confirms operational pause amid discussions for funding
- 02/14/23
- Virgin Orbit provides update on U.K. mission anomaly
- 02/03/23
- Virgin Orbit, SatRev announce follow-on launch services agreement
- 02/08/23
- CMS grants Spectrum permanent J-Code for Rolvedon injection
- 01/04/23
- Spectrum announces that CMO Francois Lebel, M.D. steps down
- 12/06/22
- Spectrum announces Rolvedon added to latest NCCN Guidelines
- 11/25/22
- Spectrum receives CRL from FDA regarding NDA for poziotinib
- 03/08/23
- Spotify introduces Spotify for Podcasters, offering more 'access to innovation'
- 01/31/23
- Spotify rises 9.8%
- 01/31/23
- Spotify reports Q4 MAUs up 20% y/y to 489M
- 01/26/23
- Spotify tweets 'everything's looking much better now'
- 03/20/23
- Charles Schwab director buys $200K in common stock
- 03/17/23
- Charles Schwab reports $16.5B in core net new assets over past five trading days
- 03/16/23
- Charles Schwab director buys $233.5K in common stock
- 03/15/23
- Charles Schwab director buys $2.0M in common stock
- 03/22/23
- Pacific Western Bank determines not to move forward with capital raise
- 03/22/23
- Pacific Western Bank reports $11.4B in available cash as of March 20
- 03/20/23
- PacWest Bancorp says bank continues to have 'solid liquidity'
- 03/16/23
- PacWest Bancorp trading resumes
OLLI Ollie's Bargain Outlet - 03/22/23
- Ollie's Bargain Outlet jumps 11% to $59.00 after Q4 earnings beat and FY23 guide
- 10/17/22
- Ollie's Bargain Outlet appoints Rob Helm as CFO
- 03/21/23
- Novartis alpelisib granted FDA orphan designation
- 03/21/23
- Novartis' Sandoz receives FDA approval for biosimilar Hyrimoz HCF
- 03/17/23
- Novartis terminates collaboration and license pact with Sangamo
- 03/16/23
- Novartis' Tafinlar + Mekinist approved by FDA for pediatric patients
- 02/08/23
- Nestle Purina recalls select lots of dry dog food over vitamin D concerns
- 02/01/23
- Nestle Canada announces wind down, exit of Frozen Meals & Pizza business
- 12/12/22
- Fonterra and Nestle agree to sale of DPA Brazil joint venture
- 11/29/22
- Nestle to explore strategic options for peanut allergy treatment
- 03/21/23
- Nike pares afterhours gains, down 0.9% after Q4 and FY23 outlook
- 03/21/23
- Nike jumps 4% to $131.00 after Q3 earnings beat
- 03/21/23
- Nike reports Q3-end inventories at $8.9B, up 16% from last year
- 03/21/23
- Nike reports Direct sales up 17% at $5.3B
- 03/21/23
- Nvidia announces availability of new products featuring H100 Tensor Core GPU
- 03/15/23
- Facebook Ireland violated law over data use, Amsterdam court ruled
- 03/15/23
- Oportun Financial expands executive team with key new hires
- 03/14/23
- Meta targeting summer to complete analysis from hybrid work year of learning
- 02/28/23
- Luminar off earlier highs, goes red after Q4 business update at 'Luminar Day'
- 02/28/23
- Luminar unveils new Iris+ sensor, announces Luminar AI Engine
- 02/28/23
- Luminar partners with Swiss Re to launch insurance program
- 02/22/23
- Luminar up 15% to $6.62 after announcing expansion of Mercedes-Benz partnership
- 03/22/23
- Inozyme expects cash to fund requirements into 4Q24
- 03/22/23
- Inozyme appoints Matthew Winton as COO
- 03/22/23
- Inozyme CEO Axel Bolte to retire, Douglas Treco to succeed
- 02/16/23
- Inozyme announces anticipated milestones
- $244.25 /
+1.245 (+0.51%) - 02/21/23
- Bath & Body Works appoints Hershey CFO Voskuil to board
- 12/07/22
- Hershey announces first bilingual manufacturing facility
- 10/20/22
- Hershey signs new solar power purchase agreement with National Grid Renewables
- 02/15/23
- Host Hotels provides RevPAR outlook for next three quarters
- 02/15/23
- Host Hotels provides update on Hurricane Ian damage
- 12/15/22
- Host Hotels board authorizes special dividend of 20c per share
- 11/29/22
- Host Hotels appoints Mari Sifo as EVP, Chief Human Resources Officer
- 01/09/23
- HealthEquity announces HSA sales outlook
- 09/22/22
- Director of HealthEquity Sacks sells $1.8M in company shares
- 09/22/22
- Director of HealthEquity Sacks sells $1.8M in company shares
- 03/22/23
- GameStop rises 40.7%
- 03/22/23
- GameStop rises 32.9%
- 03/22/23
- GameStop rises 45.0%
- 03/21/23
- GameStop jumps nearly 33% to over $23 after reporting Q4 profit
- $14.21 /
+3.275 (+29.96%) - 03/22/23
- 89bio up 47% to $16.10 after announcing positive pegozafermin trial data
- 03/22/23
- 89bio's pegozafermin trial statistically significant in critical histology
- 03/05/23
- 89bio presents new analysis of data from Phase 2 ENTRIGUE trial of pegozafermin
- 12/12/22
- 89bio announces publication of Phase 1b/2a pegozafermin study results
- 02/27/23
- Krispy Kreme confirms expanded market test with McDonald's
- 12/15/22
- Krispy Kreme down 4% amid investor day presentations
- 10/18/22
- Krispy Kreme up 8% after reports of McDonald's testing donut sales partnership
- 09/26/22
- Krispy Kreme offers free coffee on National Coffee Day
- 03/22/23
- Carvana rises 23.6%
- 03/22/23
- Carvana rises 16.3%
- 03/22/23
- Carvana rises 22.8%
- 03/22/23
- Carvana trading resumes
CSSE Chicken Soup for the Soul - 01/19/23
- Chicken Soup for the Soul acquires North American rights to Devil's Peak
- 10/18/22
- Chicken Soup teams with Publicis' APX Content Ventures on new reality series
- 10/13/22
- Chicken Soup for the Soul says Crackle button to be added to Hisense Smart TVs
- 10/05/22
- Chicken Soup for the Soul Entertainment appoints Phil Oppenheim CCO
- $199.80 /
-4.905 (-2.40%) - 03/17/23
- Boeing awarded $1.95B Army contract modification
- 03/14/23
- Boeing reports 28 commercial airplane deliveries, 5 orders in February
- 03/14/23
- Saudi Arabian Airlines selects up to 49 Boeing 787 Dreamliners
- 03/14/23
- Riyadh Air choses Boeing 787 Dreamliner to power its global launch
- 03/15/23
- Array Technologies reschedules earnings, needs more time to file annual report
- 03/03/23
- Avangrid announces intent to deploy more than $30M in solar trackers from Array
- 01/30/23
- Array Technologies names Manning as Chief Operations Officer
- 11/08/22
- Array Technologies appoints Jokinen to board of directors
- 03/21/23
- Altimmune falls 35% to $7.15 after initerim MOMENTUM Phase 2 trial data
- 03/21/23
- Altimmune announces reuslts from interim analysis of MOMENTUM Phase 2 trial
- 01/04/23
- Altimmune appoints Jordt as Chief Business Officer
- 12/20/22
- Altimmune announces topline results from 24-week trial of pemvidutide
- 03/22/23
- AbbVie receives CRL from FDA for NDA for ABBV-951
- 03/19/23
- AbbVie announces late-breaking results for SKYRIZI study
- 02/27/23
- AbbVie receives CHMP opinion recommending approval for upadacitinib
- 02/23/23
- AbbVie, Capsida announce expanded genetic medicines for eye diseases pact
- 03/22/23 BofA
- Nike inventory progress coming at expense of margins, says BofA
- 03/22/23 Evercore ISI
- Nike added to 'Tactical Outperform' list at Evercore ISI
- 03/22/23 Piper Sandler
- Nike price target raised to $112 from $105 at Piper Sandler
- 03/22/23 Jefferies
- Nike price target raised to $160 from $140 at Jefferies
- 03/16/23 Chardan
- Immunome price target lowered to $8 from $9 at Chardan
- 03/01/23 Guggenheim
- Guggenheim starts AbbVie with a Buy on diversified growth
- 02/28/23 Guggenheim
- AbbVie initiated with a Buy at Guggenheim
- 02/22/23 BMO Capital
- AbCellera price target lowered to $32 from $40 at BMO Capital
- 03/22/23 RBC Capital
- PacWest provides detailed update on deposit balances, says RBC Capital
- 03/20/23 Piper Sandler
- Piper confident PacWest can make it through liquidity crunch
- 03/20/23 DA Davidson
- PacWest Bancorp price target lowered to $26 from $29 at DA Davidson
- 03/13/23 DA Davidson
- PacWest Bancorp upgraded to Buy at DA Davidson following 54% drop in stock
- 12/08/22 Wedbush
- GameStop price target lowered to $5.30 from $6 at Wedbush
- 10/13/22 Jefferies
- GameStop transferred with a Hold at Jefferies
- 08/16/22 B. Riley
- B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell
- 07/22/22 Wedbush
- GameStop price target lowered to $7.50 from $30 at Wedbush
- 03/22/23 Guggenheim
- Array Technologies price target lowered to $35 from $36 at Guggenheim
- 03/09/23 Citi
- Array Technologies initiated with a Neutral at Citi
- 03/07/23 Piper Sandler
- Array Technologies price target lowered to $26 from $28 at Piper Sandler
- 03/01/23 Scotiabank
- Array Technologies initiated with an Outperform at Scotiabank
- 03/22/23 KeyBanc
- Meta Platforms upgraded to Overweight from Sector Weight at KeyBanc
- 03/21/23 Morgan Stanley
- Meta Platforms upgraded to Overweight from Equal Weight at Morgan Stanley
- 03/20/23 Loop Capital
- Meta Platforms price target raised to $220 from $188 at Loop Capital
- 03/20/23 Edward Jones
- Meta Platforms upgraded to Buy from Hold at Edward Jones
- 03/22/23 Guggenheim
- Spotify upgraded to Buy at Guggenheim on music industry growth potential
- 03/22/23 Guggenheim
- Spotify upgraded to Buy from Neutral at Guggenheim
- 03/10/23 BofA
- Spotify price target raised to $143 from $120 at BofA
- 03/01/23 Redburn
- Spotify upgraded to Buy from Neutral at Redburn
- 03/22/23 Guggenheim
- Warner Music upgraded to Buy at Guggenheim on music industry growth potential
- 03/22/23 Guggenheim
- Warner Music upgraded to Buy from Neutral at Guggenheim
- 01/30/23 Deutsche Bank
- Warner Music price target raised to $43 from $37 at Deutsche Bank
- 01/23/23 Barclays
- Warner Music downgraded to Equal Weight from Overweight at Barclays
- 03/22/23 Truist
- Krispy Kreme upgraded to Buy at Truist on volume growth, FX tailwinds
- 03/22/23 Truist
- Krispy Kreme upgraded to Buy from Hold at Truist
- 02/14/23 HSBC
- Krispy Kreme price target lowered to $14 from $15 at HSBC
- 01/17/23 Morgan Stanley
- Krispy Kreme downgraded to Equal Weight from Overweight at Morgan Stanley
- 03/22/23 Stifel
- Stifel argues sympathy trading not a predictor for Viking's pending VK2735 data
- 03/21/23 Goldman Sachs
- Altimmune downgraded to Neutral from Buy at Goldman Sachs
- 03/21/23 William Blair
- William Blair says Viking bull thesis intact after Altimmune data
- 03/21/23 H.C. Wainwright
- Altimmune attractive after 'overdone' selloff, says H.C. Wainwright
- 03/21/23 Goldman Sachs
- Luminar downgraded to Sell from Neutral at Goldman Sachs
- 03/14/23 Citi
- Luminar price target lowered to $19 from $20 at Citi
- 03/06/23 JPMorgan
- Luminar price target raised to $20 from $15 at JPMorgan
- 03/01/23 Deutsche Bank
- Luminar price target lowered to $14 from $15 at Deutsche Bank
- 01/26/23 Citi
- Novartis downgraded to Neutral from Buy at Citi
- 01/24/23 Lake Street
- Harrow Health price target raised to $24 from $17 at Lake Street
- 01/06/23 Morgan Stanley
- Novartis downgraded to Underweight from Equal Weight at Morgan Stanley
- 01/03/23 JPMorgan
- Novartis upgraded to Neutral from Underweight at JPMorgan
CSSE Chicken Soup for the Soul - 03/22/23 B. Riley
- Chicken Soup for the Soul price target lowered to $11 from $24 at B. Riley
- 11/15/22 Craig-Hallum
- Chicken Soup for the Soul price target lowered to $14 from $22 at Craig-Hallum
- 11/15/22 Needham
- Chicken Soup for the Soul price target lowered to $10 from $15 at Needham
- 08/12/22 DA Davidson
- Chicken Soup for the Soul price target raised to $52 from $40 at DA Davidson
- $199.80 /
-4.905 (-2.40%) - 03/22/23 Wells Fargo
- Boeing price target lowered to $230 from $240 at Wells Fargo
- 03/16/23 Northcoast
- Boeing initiated with a Neutral at Northcoast
- 03/15/23 Susquehanna
- Boeing February deliveries down but Q1 remain on track , says Susquehanna
- 03/06/23 Jefferies
- Boeing reconfiguration requirements 'not a new issue,' says Jefferies
- 03/17/23 Canaccord
- Virgin Orbit rating, target put under review at Canaccord after operations halt
- 01/11/23 Canaccord
- Virgin Orbit price target lowered to $6 from $12
- 10/11/22 Credit Suisse
- Virgin Orbit initiated with Underperform on elevated cash burn at Credit Suisse
- 10/11/22 Credit Suisse
- Virgin Orbit initiated with an Underperform at Credit Suisse
- 03/06/23 RBC Capital
- Nestle downgraded to Underperform from Sector Perform at RBC Capital
- 02/15/23 Bryan Garnier
- Nestle initiated with a Neutral at Bryan Garnier
- 01/19/23 Berenberg
- Nestle price target raised to CHF 130 from CHF 126 at Berenberg
- 01/18/23 Jefferies
- Nestle upgraded to Hold from Underperform at Jefferies
- $14.21 /
+3.275 (+29.96%) - 03/22/23 Raymond James
- Raymond James doubles 89bio price target to $50 after FGF21 'wins again'
- 03/22/23 Raymond James
- 89bio price target raised to $50 from $25 at Raymond James
- 03/22/23 Cantor Fitzgerald
- 89bio price target raised to $45 from $34 at Cantor Fitzgerald
- 03/22/23 Cantor Fitzgerald
- 89bio NASH data show high statistical significance, says Cantor Fitzgerald
- 02/27/23 Citi
- Carvana price target raised to $11 from $5.50 at Citi
- 02/24/23 Deutsche Bank
- Carvana price target lowered to $10 from $16 at Deutsche Bank
- 02/24/23 BofA
- Carvana price target raised to $12 from $10 at BofA
- 02/24/23 Wedbush
- Wedbush keeps $1 target on Carvana after 'awful' quarter
OLLI Ollie's Bargain Outlet - 02/28/23 Piper Sandler
- Ollie's Bargain Outlet price target raised to $72 from $60 at Piper Sandler
- 02/06/23 Wells Fargo
- Ollie's Bargain Outlet price target raised to $67 from $60 at Wells Fargo
- 12/08/22 Jefferies
- Ollie's Bargain Outlet price target lowered to $60 from $65 at Jefferies
- 12/08/22 Craig-Hallum
- Ollie's Bargain Outlet price target lowered to $65 from $70 at Craig-Hallum
- 03/22/23 Barclays
- Charles Schwab price target lowered to $61 from $79 at Barclays
- 03/15/23 Credit Suisse
- Charles Schwab upgraded to Outperform from Neutral at Credit Suisse
- 03/14/23 JPMorgan
- Schwab funding concerns 'significantly de-risked,' says JPMorgan
- 03/14/23 Piper Sandler
- Charles Schwab price target lowered to $95 from $100 at Piper Sandler
- 03/22/23 Compass Point
- Host Hotels downgraded to Neutral from Buy at Compass Point
- 02/16/23 Stifel
- Host Hotels price target lowered to $21 from $22 at Stifel
- 01/09/23 Jefferies
- Hilton downgraded to Hold from Buy at Jefferies
- 01/09/23 Jefferies
- Marriott downgraded to Hold from Buy at Jefferies
- $244.25 /
+1.245 (+0.51%) - 03/20/23 Deutsche Bank
- Hershey price target lowered to $237 from $246 at Deutsche Bank
- 03/17/23 Erste Group
- Hershey upgraded to Buy from Hold at Erste Group
- 02/02/23 Goldman Sachs
- Hershey price target raised to $277 from $255 at Goldman Sachs
- 01/06/23 Evercore ISI
- Hershey downgraded to In Line from Outperform at Evercore ISI
- 03/15/23 Wedbush
- Petco price target lowered to $12 from $17 at Wedbush
- 03/13/23 Citi
- Citi downgrades Petco into results on weakening consumer
- 03/13/23 Citi
- Petco downgraded to Neutral from Buy at Citi
- 12/01/22 RBC Capital
- Petco price target lowered to $16 from $17 at RBC Capital
- 02/03/23 Wells Fargo
- HealthEquity price target lowered to $89 from $101 at Wells Fargo
- 01/24/23 Deutsche Bank
- HealthEquity price target raised to $72 from $68 at Deutsche Bank
- 01/03/23 BTIG
- Sharecare named Top Pick for first half of 2023 at BTIG
- 12/16/22 Baird
- HealthEquity bullish Fresh Pick designation extended at Baird
- 07/19/22 Piper Sandler
- Promising Inozyme results offer meaningful upside for stock, says Piper Sandler
- 05/26/22 Jefferies
- Inozyme initiated with a Hold at Jefferies
- 04/14/22 Piper Sandler
- Investors should take close look at Inozyme, says Piper Sandler
- 04/04/22 Piper Sandler
- Piper likes Inozyme shares up to $40 after 'promising' update
- 01/31/23 H.C. Wainwright
- Spectrum Q4 sales dramatically beat estimates, says H.C. Wainwright
- 11/25/22 H.C. Wainwright
- Spectrum price target lowered to $4 from $6 at H.C. Wainwright
- 11/16/22 B. Riley
- Spectrum downgraded to Neutral from Buy at B. Riley
- 09/23/22 H.C. Wainwright
- Spectrum price target lowered to $6 from $9 at H.C. Wainwright
- 03/22/23
- Petco sees FY23 revenue $6.15B-$6.275B, consensus $6.36B
- 03/22/23
- Petco reports Q4 adjusted EPS 23c, consensus 24c
- 02/09/23
- Warner Music reports Q1 EPS 23c, consensus 26c
- 11/22/22
- Warner Music reports Q4 EPS 28c, consensus 13c
- 03/22/23
- Spectrum reports Q4 EPS (5c), consensus (11c)
- 01/31/23
- Spectrum rallies after preliminary Q4 sales crush estimates
- 11/10/22
- Spectrum reports Q3 EPS (12c), consensus (15c)
- 01/31/23
- Spotify sees Q1 revenue EUR 3.1B, gross margin 24.9%
- 01/31/23
- Spotify reports Q4 EPS (EUR 1.40) vs. (EUR 0.20) last year
- 10/25/22
- Spotify reports Q3 Operating loss EUR (228M) vs. profit EUR 75M prior
- 01/18/23
- Charles Schwab reports Q4 adjusted EPS $1.07, consensus $1.09
- 01/17/23
- Notable companies reporting before tomorrow's open
- 10/27/22
- Charles Schwab backs 11%-13% year-over-year revenue growth outlook
- 01/26/23
- PacWest Bancorp reports Q4 EPS 33c, consensus 97c
- 10/19/22
- PacWest Bancorp reports Q3 EPS 1.02, consensus $1.07
OLLI Ollie's Bargain Outlet - 03/22/23
- Ollie's Bargain Outlet sees 2023 adjusted EPS $2.49-$2.58, consensus $2.38
- 03/22/23
- Ollie's Bargain Outlet reports Q4 adjusted EPS 84c, consenus 79c
- 03/21/23
- Notable companies reporting before tomorrow's open
- 02/01/23
- Novartis sees core operating income to grow mid single digit percentage in 2023
- 02/01/23
- Novartis reports Q4 core EPS $1.52, consensus $1.44
- 10/25/22
- Novartis confirms mid single digit sales, core operating income guidance
- 10/25/22
- Novartis reports Q3 core EPS $1.58 vs. $1.71 last year
- 02/16/23
- Nestle confirms 2025 targets
- 02/16/23
- Nestle sees FY23 organic sales growth 6%-8%
- 02/16/23
- Nestle reports FY22 sales CHF 94.42B vs. CHF 87.09B last year
- 11/29/22
- Nestle sees constant currency earnings growth of 6%-10% through 2025
- 03/21/23
- Nike sees FY23 revenue up high single digits, gross margins down 250bps
- 03/21/23
- Nike reports Q3 EPS 79c, consensus 55c
- 03/21/23
- Notable companies reporting after market close
- 12/20/22
- Nike sees FY23 revenue growth in mid teens, consensus $49.01B
- 02/01/23
- Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B
- 02/01/23
- Meta Platforms reports Q4 EPS $1.76, consensus $2.22
- 02/01/23
- Notable companies reporting after market close
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 02/28/23
- Luminar sees FY23 revenue growth of 'at least 100%,' consensus $116.14M
- 02/28/23
- Luminar reports Q4 EPS (26c), consensus (21c)
- 11/02/22
- Luminar reports Q3 EPS (18c), consensus (20c)
- 11/02/22
- Notable companies reporting after market close
- 03/22/23
- Inozyme reports 2022 EPS ($1.78), consensus ($1.81)
- 11/10/22
- Inozyme reports Q3 EPS (38c), consensus (43c)
- $244.25 /
+1.245 (+0.51%) - 03/22/23
- Hershey backs FY23 adjusted EPS growth view 9%-11%, consensus $9.35
- 02/02/23
- Hershey sees FY23 adjusted EPS up 9%-11%, consensus $8.94
- 02/02/23
- Hershey reports Q4 adjusted EPS $2.02, consensus $1.77
- 02/01/23
- Notable companies reporting before tomorrow's open
- 02/15/23
- Host Hotels reports Q4 EPS 20c, consensus 19c
- 11/02/22
- Host Hotels reports Q3 EPS 16c, consensus 17c
- 03/21/23
- HealthEquity sees FY24 EPS $1.74-$1.87, consensus $1.76
- 03/21/23
- HealthEquity reports Q4 EPS 0c, consensus 35c
- 12/06/22
- HealthEquity sees FY24 revenue $950M-$970M, consensus $948.4M
- 12/06/22
- HealthEquity raises FY23 EPS view to $1.26-$1.35 from $1.23-$1.32
- 03/21/23
- GameStop reports Q4 EPS 16c, consensus (13c)
- 12/07/22
- GameStop reports Q3 EPS (31c), consensus (28c)
- $14.21 /
+3.275 (+29.96%) - 03/10/23
- 89bio reports Q4 EPS (48c), consensus (69c)
- 11/10/22
- 89bio reports Q3 EPS (57c), consensus (80c)
- 02/15/23
- Krispy Kreme sees FY23 adjusted EPS 31c-34c, consensus 36c
- 02/15/23
- Krispy Kreme reports Q4 adjusted EPS 11c, consensus 10c
- 12/15/22
- Krispy Kreme sees FY26 revenue about $2.15B, adjusted EPS about 53c
- 12/15/22
- Krispy Kreme sees FY23 revenue up low double digits in constant currency
- 03/22/23
- Carvana sees Q1 revenue $2.4B-$2.6B, consensus $2.7B
- 02/23/23
- Carvana reports Q4 EPS ($7.61) vs ($1.02) last year
- 02/23/23
- Notable companies reporting after market close
- 11/03/22
- Carvana sees sequential reduction in retail units sold in Q4
CSSE Chicken Soup for the Soul - 11/14/22
- Chicken Soup for the Soul reports Q3 EPS ($1.13), consensus ($1.18)
- $199.80 /
-4.905 (-2.40%) - 01/25/23
- Boeing reports Q4 core EPS ($1.75), consensus 26c
- 01/24/23
- Notable companies reporting before tomorrow's open
- 10/26/22
- Boeing reports Q3 core EPS ($6.18), consensus 2c
- 03/21/23
- Array Technologies sees FY23 adjusted EPS 75c-85c, consensus 78c
- 03/21/23
- Array Technologies reports Q4 adjusted EPS 10c, consensus 8c
- 03/02/23
- Array Technologies sees 2023 adjusted EPS 75c-85c, consensus 95c
- 02/28/23
- Altimmune reports Q4 EPS (43c), consensus (50c)
- 11/10/22
- Altimmune reports Q3 EPS (48c), consensus (50c)
- 02/09/23
- AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08
- 02/09/23
- AbbVie sees FY23 revenue about $52B, consensus $54.21B
- 02/09/23
- AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65
- 02/09/23
- AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56
|